Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.1. This indicates a minor system update to the page rendering rather than a modification of the study details.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.1 for the page, reflecting a minor release of the site software. This appears to be an internal update rather than a change to the study text or data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows recruitment has closed and includes new guidance sections to help readers understand the study record and enrollment process.SummaryDifference0.3%

- Check36 days agoChange DetectedThe page's revision version was updated from v3.5.4 to v3.5.5, signaling a small maintenance update to the page's content or metadata. It does not reflect changes to the study data or description.SummaryDifference0.0%

- Check43 days agoChange DetectedA new publication citation titled 'Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma' was added to the Publications section, referencing a 2026 Ann Oncol article related to the study. This links long-term survival data to the study record.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated to v3.5.4, indicating a minor system update to the page rendering.SummaryDifference0.0%

Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.